CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $42,000 | -23.6% | 20,347 | +0.4% | 0.00% | – |
| Q4 2021 | $55,000 | +22.2% | 20,270 | +102.1% | 0.00% | – |
| Q3 2021 | $45,000 | -91.0% | 10,031 | +35.8% | 0.00% | – |
| Q4 2017 | $502,000 | -96.7% | 7,385 | -96.0% | 0.00% | -100.0% |
| Q3 2017 | $15,261,000 | -25.0% | 185,211 | -14.7% | 0.01% | -28.6% |
| Q2 2017 | $20,337,000 | – | 217,205 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |